logo
Barbie just released a doll with diabetes. Here's why a B.C. content creator is calling it 'incredible'

Barbie just released a doll with diabetes. Here's why a B.C. content creator is calling it 'incredible'

Yahoo3 days ago
Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page.
When Bella Bucchiotti was 19, she was diagnosed with Type 1 diabetes (T1D).
'It came completely out of the blue, and adjusting to life with T1D was overwhelming,' the B.C.-based content creator and founder of the site xoxobella.com recalls. 'There's no easing into it — one day you're fine, and the next you're figuring out insulin doses and how every bite of food might impact your blood sugar.'
A chronic autoimmune disease that prevents your pancreas from making insulin, people with T1D require insulin therapies in order to survive.
The diagnosis changed everything for Bucchiotti. Life, she says, became a constant balancing act.
'No one really sees all the mental load that comes with it,' Bucchiotti says. 'There's a huge learning curve, especially at the start — figuring out how your body responds to food, exercise, stress, even lack of sleep. Every day is different, and that can be exhausting.'
Developing the tools and knowledge to help manage her diabetes, Bucchiotti says she's learned to live with Type 1, without letting it define her.
Bucchiotti isn't alone in her diagnosis. According to the research and advocacy organization Breakthrough T1D, about 300,000 Canadians have T1D, with that number forecast to increase to 455,580 by 2040.
Most diagnoses come between ages 10 and 14, according to Breakthrough T1D. But a diagnosis can come at any age. And that diagnosis can come as a shock.
Looking to raise awareness about Type 1 diabetes, Mattel Inc. is releasing its first Barbie doll with the disease. The move, Bucchiotti says, could be helpful to people, especially young girls, who might be facing a T1D diagnosis.
'It's a way of being seen and not singled out,' she says. 'That really matters, especially in the beginning when you're learning how to manage it all and you feel so different from everyone around you.'
As a new mother, Bucchiotti says the representation can impart an important message to children living with T1D: 'You're not broken, and you're not alone.'
'The mental-health side of diabetes is something we don't talk about enough, especially the isolation,' she says. 'A toy like this sends a message that living with Type 1 diabetes is just one part of who you are, and it doesn't have to make you feel like you don't belong.'
Created in partnership with Breakthrough T1D, the new doll wears a continuous glucose monitor (CGM), an important tool that measures a person's blood-glucose level, held in place with a Barbie-pink piece of heart-shaped medical tape.
'Even now, seeing someone else with an insulin pump or CGM at the coffee shop makes me feel like I'm not alone,' Bucchiotti notes of the noticeable inclusion. 'That quiet connection is something really special, because no one else quite understands how tough some days can be.'
The doll also features an insulin pump, a small device that allows for insulin dosing as needed, at the waist.
'It gives kids someone — even in doll-form — who truly reflects their experience,' Bucchiotti remarks of the realistic elements of the polka-dot-dress-wearing Barbie. 'Instead of feeling different or ashamed, they see something familiar, something that makes their condition feel normal.
'A Barbie with a CGM might seem like a small gesture, but for a child navigating a life-changing diagnosis, it can bring comfort, confidence and a sense of belonging. It can also open the door for conversations with friends and classmates, helping to build empathy and break down stigma.'
Part of the Barbie Fashionistas' line, the Barbie doll with Type 1 joins a collection of more than 175 looks who feature a wide variety of skin tones, eye and hair colours, body types, ethnicities, disabilities and more.
The latest doll reflects an 'important step' in Mattel Inc.'s commitment to inclusivity and representation, according to Krista Berger, senior vice-president of Barbie and global head of dolls.
For Bucchiotti, the doll represents an important point of connection for the community of people around the world living with the disease.
'Type 1 diabetes is relentless, but it builds a kind of strength you don't expect,' she says. 'It's not always easy, but the T1D community is incredibly supportive.
'Sometimes it's a message from someone who's been there, or even just spotting a CGM on a stranger across the room — those small moments of connection remind you that you're not in this alone.'
Aharris@postmedia.com
Opinion: Living with multiple sclerosis is difficult. Living in B.C. makes it harder
Margot Robbie would like to make a Barbie musical
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RFK Jr wants Canada to pardon 400 ostriches
RFK Jr wants Canada to pardon 400 ostriches

Yahoo

time2 hours ago

  • Yahoo

RFK Jr wants Canada to pardon 400 ostriches

The Canadian government ordered 400 ostriches to be culled after they were exposed to bird flu, but U.S. Health and Human Services Secretary Robert F. Kennedy Jr. wants to save the flock. Universal Ostrich Farms in British Columbia was ordered to cull the flightless birds after avian flu was detected last December, CBC reported. A month later, 69 birds died. A court battle has ensued, with the farm owners arguing the ostriches should be kept alive to be studied for potential treatments. Although the court rejected the initial argument, the federal appeals court last month paused the order as it reviewed the matter; the court heard arguments in the case this week. Amid the legal challenges the birds have found an unlikely ally to the south: RFK Jr. 'The Secretary has urged Canada not to kill the ostriches but to do further testing to try to better understand the virus,' a spokesperson for the U.S. Department of Health and Human Services told Politico. HHS Secretary Robert F. Kennedy Jr. wants to save 400 Canadian ostriches from being culled (REUTERS) The health secretary wrote a letter to the president of the Canadian Food Inspection Agency in May, urging the agency not to go through with plans to eradicate the flock and instead test the birds' antibodies: 'We believe significant scientific knowledge may be garnered from following the ostriches in a controlled environment at the Universal Ostrich Farm.' The cull was ordered as part of a so-called 'stamping-out' policy, used to mitigate the risk of the virus spreading to humans or animals, according to the agency. A screengrab from a video capturing two ostriches resting at the Universal Ostrich Farm, where the Canadian government has ordered for 400 birds to be culled due to avian flu exposure (Katie Pasitney / Facebook) 'Allowing a domestic poultry flock known to be exposed to [bird flu] to remain alive means a potential source of the virus persists. It increases the risk of reassortment or mutation of the virus, particularly with birds raised in open pasture where there is ongoing exposure to wildlife,' the agency explained in a May release after the federal court dismissed the farm owners' applications for judicial review. This week, Kennedy — along with Trump's Centers for Medicare & Medicaid Services Administrator Mehmet Oz and billionaire John Catsimatidis — sent letters to Prime Minister Mark Carney pressing his government to alter its policy, Politico reported. Hundreds of birds remain symptom-free months after 69 birds died after being exposed to bird flu, according to the farm owners' lawyer (Katie Pasitney) According to CBC, Katie Pasitney, whose parents own the farm, thanked the trio for their efforts, saying on Tuesday: "I guess we'll just see where that goes from here because we do know that Dr. Oz and RFK are very passionate about this, just as well as John Catsimatidis." In court on Tuesday, Umar Sheikh, a lawyer for the farm owners, similarly argued that the government's policy was too strict, noting that hundreds of ostriches still exhibit no symptoms of avian flu. Only two birds tested positive for the virus before the cull was ordered, he said. "We would ask questions such as why 100 percent destruction needs to occur based on 0.5 percent confirmed infection?" Sheikh asked the court, according to CBC. Aileen Jones, a lawyer for the agency, argued that the court has already determined the 'stamping-out policy is a reasonable policy,' the outlet reported. Solve the daily Crossword

Lobe Sciences Ltd. Announces Debt Settlement
Lobe Sciences Ltd. Announces Debt Settlement

Associated Press

time2 hours ago

  • Associated Press

Lobe Sciences Ltd. Announces Debt Settlement

VANCOUVER, BC / ACCESS Newswire / July 16, 2025 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a biopharmaceutical company committed to developing innovative treatments for underserved diseases, today announced that it has settled an outstanding debt of CAD$11,596.22 owed to Gibbsons P.C. for legal services previously provided to the Company. In satisfaction of this obligation, Lobe has issued 546,206 common shares of the Company to Gibbson Law P.C. at a deemed price of CAD$0.02123 per share. The shares were issued on May 13, 2025, and are subject to applicable regulatory hold periods under Canadian securities laws. About Lobe Sciences - Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F) is a biopharmaceutical company focused on developing innovative therapies for rare and underserved conditions. Through its wholly owned subsidiary, Altemia, Inc., and its majority-owned subsidiary, Cynaptec Pharmaceuticals, Inc., Lobe is advancing a patented lipid-based platform for treating Sickle Cell Disease and a novel oral analog of psilocin-Conjugated Psilocin™-targeted at Chronic Cluster Headache and other neurological disorders. These programs address significant unmet medical needs with the potential to improve outcomes in both hematologic and neuropsychiatric patient populations. For further information: Dr. Fred D. Sancilio, CEO Lobe Sciences Ltd. Investor and Media [email protected] Phone: +1 (949) 505-5623 Cautionary Statement Regarding 'Forward-Looking' Information This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, including, without limitation: the Company's intention to raise funds for clinical trials, the innovativeness of Conjugated Psilocin™. the anticipated focus and timing or efficiency of the Company's research and development activities; the potential for the Company's products to meet unmet medical needs, the anticipated use of proceeds from the offering, the intended development plans for Cynaptec™, the intention of Lobe Sciences to provide certain services to Cynaptec, the potential exercise of the option and intended use of proceeds therefrom and the potential ability to raise funds for clinical development are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as 'intends' or 'anticipates', or variations of such words and phrases or statements that certain actions, events or results 'may', 'could', 'should' or 'would' or occur. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including, among other things, that: the Company's planned activities will be able to create shareholder value and address serious unmet medical needs; the Company will continue to pursue its planned research and development activities, and that the Company will be able to raise funds among others. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important risks that may cause actual results to vary, include, without limitation, the risk that: the Company's planned activities will be unable to create shareholder value or address the targeted unmet medical needs; the Company is unable to obtain the desired results from its current research and development activities; and the Company is unable to raise funds or to do so on the timelines anticipated. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS NEWS RELEASE. SOURCE: Lobe Sciences Ltd. press release

Luke Michael Howard Announces Breakthrough Anxiety Treatment with Revolutionary Hypnosis Protocol
Luke Michael Howard Announces Breakthrough Anxiety Treatment with Revolutionary Hypnosis Protocol

Associated Press

time2 hours ago

  • Associated Press

Luke Michael Howard Announces Breakthrough Anxiety Treatment with Revolutionary Hypnosis Protocol

Introducing Luke Michael Howard: A Leader in Clinical Hypnosis Canada, July 17, 2025 -- Luke Michael Howard, a Clinical Hypnotist and the founder of LUKEnosis Hypnosis, is widely recognized for his work in the field of mental health. With 25 years of experience, Luke has helped thousands of clients address various mental, emotional, and physiological issues. His methods are direct, impactful, and offer meaningful change for many individuals, presenting an alternative to traditional therapies. With over a million social media interactions, Luke has developed a reputation for creating innovative approaches that support personal transformation. Luke's Anxiety Removal Protocol: A Medication-Free Approach Luke Michael Howard's 'Anxiety Removal Protocol' is designed for individuals struggling with anxiety and panic attacks, offering them a medication-free alternative. The technique focuses on reprogramming the subconscious mind to address the underlying causes of anxiety and panic. While the protocol may provide faster results for some individuals compared to traditional therapy, outcomes can vary, and it is essential for participants to have realistic expectations. This protocol presents a natural approach to anxiety relief, emphasizing mental wellness without the reliance on medication. The method is suitable for individuals aged 16-65, including those who have struggled with anxiety for years or decades. Many have found this alternative to be an accessible option in their journey toward emotional health, but as with any therapeutic method, the results will differ from person to person. A Recognized Leader in the Field of Hypnosis Luke's expertise in clinical hypnosis has been acknowledged across the field. He was invited to deliver a TEDTalk on learning skills to students at the University of Ottawa, reinforcing his status as an authority in the field. Additionally, he has been recognized as the No. 1 Hypnotist in Toronto by the Toronto Star and ranked among the top 3 Hypnotists in Ottawa by the Ottawa Top 3 website. Luke's work has been featured in several major outlets such as CBC, The Huffington Post, The Toronto Star, The Ottawa Citizen, and The Daily Mail. Luke's dedication extends globally, with speaking engagements at conferences like Hypnothoughts Live, the Canadian Hypnosis Conference, and the Michigan Hypnosis Conference. What Sets Luke Apart: Rapid Relief Without Medication Traditional anxiety therapy can often take years, and many patients rely on medications for management. Luke's approach is focused on using hypnosis to address the root causes of anxiety in a fraction of the time, though results may vary. Through his Anxiety Removal Protocol, some individuals have experienced relief within weeks. The technique offers a rapid alternative to managing anxiety, though individual success rates will depend on a range of factors, including the severity of the anxiety and the individual's unique response to hypnosis. No One Is Beyond Help Luke Michael Howard's mission is clear: to help individuals overcome anxiety, regardless of its severity. While traditional therapies may work for many, others find themselves seeking alternative solutions. Luke's protocol has been beneficial for a wide range of clients, from military personnel and government employees to individuals who have struggled with anxiety for years. Luke's core belief is that change is possible for everyone, no matter how entrenched their anxiety may seem. The results of the Anxiety Removal Protocol will depend on the person, and Luke's commitment to helping clients navigate their challenges is unwavering. About Luke Michael Howard and LUKEnosis Hypnosis Luke Michael Howard is a Clinical Hypnotist and the founder of LUKEnosis Hypnosis, specializing in anxiety and panic attack relief. With 25 years of experience, he has helped thousands of clients overcome mental and emotional health challenges. His Anxiety Removal Protocol offers a natural, medication-free alternative to managing anxiety, with results varying from person to person. Luke is also an international speaker, sharing his knowledge at global hypnosis conferences. Media Contact Luke Michael Howard Hypnotist/Lukenosis Hypnosis Email: [email protected] Website Facebook Instagram YouTube LinkedIn Contact Info: Name: Luke Michael Howard Email: Send Email Organization: Lukenosis Hypnosis Website: Release ID: 89164887 Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store